• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Copay Assistance Fund Now Open

February 1, 2019 By Dr. Jeremy Feldman

update

In the ever-shifting landscape for copay assistance you have to have patience and perseverance.  Yesterday the Copay Assistance Fund announced that they have money to give away to help PAH patients afford their medication. You can click here to apply. Or you may call 855-649-8623. There are also other phone numbers located on their site here. The Assistance Fund is an … [Read more...]

V-Wave: A New Device is Being Studied to Treat PAH

January 10, 2019 By Dr. Jeremy Feldman

It is important to assess the right ventricle of the heart of PH patients

The PAH community is fortunate to have many treatment options.  14 medications are approved and probably more coming.  But for some patients, medications are not enough.  We have long recognized that patients with congenital heart disease (abnormal communications in their heart) who have PAH have a much better prognosis. What is Atrial Septostomy? In certain parts of the … [Read more...]

How Am I Doing? Assessing Your PAH.

December 21, 2018 By Dr. Jeremy Feldman

PAH patient

Perhaps the most common question that I get asked by my patients is “How am I doing”.  This is both a simple and a complicated question.  Over the past 20 years we have developed many tools to assess how a patient with PAH is doing.  We have a long list of tests that we can perform from heart catheterization, echocardiography, blood tests, walk tests and we are continually … [Read more...]

The Holiday Season and Pulmonary Arterial Hypertension

November 21, 2018 By Dr. Jeremy Feldman

pumpkin pie holiday food salt intake

The holiday season is upon us and there will be many temptations over the next six weeks.  Is there a way to enjoy the season and avoid putting your health at risk? Watching Your Salt Intake Few meals are more American than Thanksgiving dinner.  Classic fare includes turkey with gravy, sweet potatoes, cranberry relish, green bean casserole, and pumpkin pie.  Lurking in these … [Read more...]

Pulmonary Artery Denervation as a Treatment for PAH

October 29, 2018 By Dr. Jeremy Feldman

blood cells pulmonary arteries

Pulmonary arterial hypertension is caused by abnormal changes in the pulmonary arteries of patients. These changes include increased thickness of the muscle layer of the pulmonary arteries and increased stiffness of the pulmonary arteries.  Over the last 25 years, 14 medications have been approved to try and treat these changes. These medications have resulted in dramatic … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Sotatercept (Winrevair) Approved!

By Dr. Jeremy Feldman

On March 26, 2024 the FDA approved sotatercept (brand name of Winrevair), the first new class of medication approved in

implantable remodulin pump system for pulmonary hypertension patients

2019 Update on Implanted Pump for Remodulin

By Dr. Jeremy Feldman

Although the progress of the implanted pump system for Remodulin has been a little like watching paint dry on the wall,

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives